EUROPEAN CONSENSUS TABLE ON THE USE OF BOTULINUM TOXIN TYPE A IN ADULT SPASTICITY

被引:270
作者
Wissel, Joerg [1 ]
Ward, Anthony B. [2 ]
Erztgaard, Per [3 ]
Bensmail, Djamel [4 ]
Hecht, Martin J. [5 ]
Lejeune, Thierry M. [6 ]
Schnider, Peter [7 ]
Altavista, Maria C. [8 ]
Cavazza, Stefano [9 ]
Deltombe, Thierry [10 ]
Duarte, Esther [11 ]
Geurts, Alexander C. H. [12 ,13 ]
Gracies, Jean-Michel [14 ]
Haboubi, Naseer H. J. [15 ]
Juan, Francisco J. [16 ]
Kasch, Helge [17 ]
Kaetterer, Christian [18 ]
Kirazli, Yesim [19 ]
Manganotti, Paolo [20 ]
Parman, Yesim [21 ]
Paternostro-Sluga, Tatjana [22 ]
Petropoulou, Konstantina [23 ]
Prempeh, Robert [24 ]
Rousseaux, Marc [25 ]
Slawek, Jaroslaw [26 ,27 ]
Tieranta, Niko [28 ]
机构
[1] Kliniken Beelitz GmbH, Clin Dept Neurol Rehabil, Paracelsusring 6A, DE-14547 Beelitz Heilstaetten, Germany
[2] Haywood Hosp, N Staffordshire Rehabil Ctr, Stoke On Trent, Staffs, England
[3] Linkoping Univ Hosp, Dept Rehabil Med, S-58185 Linkoping, Sweden
[4] Univ Versailles St Quentin, Hop R Poincare, Dept Phys Med & Rehabil, Garches, France
[5] Univ Erlangen Nurnberg, Dept Neurol, Bezirkskrankenhaus Kaufbeuren, Fac Med, D-8520 Erlangen, Germany
[6] Catholic Univ Louvain, Clin Univ St Luc, Dept Phys Med & Rehabil, B-1200 Brussels, Belgium
[7] Landsklinikum Wiener Neustadt & Hochegg, Dept Neurol, Wiener Neustadt, Austria
[8] S Filippo Neri Hosp Neurol Unit, Dept Neurol Sci, Rome, Italy
[9] Univ Ferrara, Dept Rehab S Giorgio Arcispeda S Anna Ferrara, I-44100 Ferrara, Italy
[10] Catholic Univ Louvain, Clin Univ Mt Godinne, Phys Med & Rehabil Dept, Yvoir, Belgium
[11] IMAS Hosp Mar & Esperanca, Serv M Fis & Rehabil, Barcelona, Spain
[12] Radboud Univ Nijmegen, Med Ctr, NL-6525 ED Nijmegen, Netherlands
[13] St Maartens Clin, Dept Rehabil, Nijmegen, Netherlands
[14] CHU Henri Mondor, Unite Neuroreeduc, Chef Serv Med Phys & Readaptat, F-94010 Creteil, France
[15] Nottingham Univ Hosp Trust, Nottingham, England
[16] Complexo Hosp Univ Vigo, Serv Med Fis & Rehabil, Vigo, Spain
[17] Aarhus Univ Hosp, Dept Neurol, Danish Pain Res Ctr, DK-8000 Aarhus, Denmark
[18] REHAB Basel, Basel, Switzerland
[19] Ege Univ, Fac Med, Phys Med & Rehabil Dept, Izmir, Turkey
[20] Univ Verona, Sect Rehabil Neurol, Dept Neurol Sci & Vis, I-37100 Verona, Italy
[21] Istanbul Univ, Istanbul Fac Med, Dept Neurol, Istanbul, Turkey
[22] Med Univ Vienna, Dept Phys Med & Rehabil, Vienna, Austria
[23] Natl Rehabil Ctr, Dept Phys & Rehabil Med 2, Athens, Greece
[24] Stirling Royal Infirm, Rehabil Med, Stirling, Scotland
[25] CHRU Lille, Hop Swynghedauw, Serv Reeduc Neurol, F-59037 Lille, France
[26] Med Univ Gdansk, St Adalbert Hosp, Dept Neurol, Gdansk, Poland
[27] Med Univ Gdansk, Dept Neurol Psychiat Nursing, Gdansk, Poland
[28] Lapland Rehabil Ctr, Rovaniemi, Finland
关键词
botulinum toxin; upper motor neurone syndrome; adult spasticity; acquired brain injury; UPPER-LIMB SPASTICITY; TERM ELECTRICAL-STIMULATION; UPPER EXTREMITY SPASTICITY; QUALITY-OF-LIFE; DOUBLE-BLIND; SHOULDER PAIN; POSTSTROKE SPASTICITY; REDUCING SPASTICITY; COST-EFFECTIVENESS; FINGER SPASTICITY;
D O I
10.2340/16501977-0303
中图分类号
R49 [康复医学];
学科分类号
100215 ;
摘要
A group of clinicians from across Europe experienced in the use of botulinum toxin type a for the treatment of spasticity following acquired brain injury gathered to develop a consensus statement on best practice in managing adults with spasticity. this consensus table summarizes the current published data, which was collated following extensive literature searches, their assessment for level of evidence and discussion among the whole group. published information is supplemented by expert opinion based on clinical experience from 16 European countries, involving 28 clinicians, who treat an average of approximately 200 patients annually, representing many thousand spasticity treatments with botulinum toxin per year.
引用
收藏
页码:13 / 25
页数:13
相关论文
共 83 条
[1]  
Al-Buhairi A R, 1998, J Stroke Cerebrovasc Dis, V7, P339, DOI 10.1016/S1052-3057(98)80052-9
[2]  
Amirali Asif, 2007, J Clin Neuromuscul Dis, V9, P306
[3]   Using translational medicine to understand clinical differences between botulinum toxin formulations [J].
Aoki, K. R. ;
Ranoux, D. ;
Wissel, J. .
EUROPEAN JOURNAL OF NEUROLOGY, 2006, 13 :10-19
[4]   Goal attainment for spasticity management using botulinum toxin [J].
Ashford, Stephen ;
Turner-Stokes, Lynne .
PHYSIOTHERAPY RESEARCH INTERNATIONAL, 2006, 11 (01) :24-34
[5]   A randomized, double-blind, placebo-controlled, dose-ranging study to compare the efficacy and safety of three doses of botulinum toxin type A (Dysport) with placebo in upper limb spasticity after stroke [J].
Bakheit, AMO ;
Thilmann, AF ;
Ward, AB ;
Poewe, W ;
Wissel, J ;
Muller, J ;
Benecke, R ;
Collin, C ;
Muller, F ;
Ward, CD ;
Neumann, C .
STROKE, 2000, 31 (10) :2402-2406
[6]   The beneficial antispasticity effect of botulinum toxin type A is maintained after repeated treatment cycles [J].
Bakheit, AMO ;
Fedorova, NV ;
Skoromets, AA ;
Timerbaeva, SL ;
Bhakta, BB ;
Coxon, L .
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2004, 75 (11) :1558-1561
[7]   A randomized, double-blind, placebo-controlled study of the efficacy and safety of botulinum toxin type A in upper limb spasticity in patients with stroke [J].
Bakheit, AMO ;
Pittock, S ;
Moore, AP ;
Wurker, M ;
Otto, S ;
Erbguth, F ;
Coxon, L .
EUROPEAN JOURNAL OF NEUROLOGY, 2001, 8 (06) :559-565
[8]   Sonography-guided injection of botulinum toxin in children with cerebral palsy [J].
Berweck, S ;
Schroeder, AS ;
Fietzek, UM ;
Heinen, F .
LANCET, 2004, 363 (9404) :249-250
[9]  
Berweck S, 2004, ADV CLIN NEUROSCI RE, V4, P28
[10]   Impact of botulinum toxin type A on disability and carer burden due to arm spasticity after stroke: a randomised double blind placebo controlled trial [J].
Bhakta, BB ;
Cozens, JA ;
Chamberlain, MA ;
Bamford, JM .
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2000, 69 (02) :217-221